Bobby Brillantes

588 total citations
2 papers, 30 citations indexed

About

Bobby Brillantes is a scholar working on Molecular Biology, Geriatrics and Gerontology and Oncology. According to data from OpenAlex, Bobby Brillantes has authored 2 papers receiving a total of 30 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Molecular Biology, 1 paper in Geriatrics and Gerontology and 1 paper in Oncology. Recurrent topics in Bobby Brillantes's work include PARP inhibition in cancer therapy (1 paper), Biochemical and Molecular Research (1 paper) and Sirtuins and Resveratrol in Medicine (1 paper). Bobby Brillantes is often cited by papers focused on PARP inhibition in cancer therapy (1 paper), Biochemical and Molecular Research (1 paper) and Sirtuins and Resveratrol in Medicine (1 paper). Bobby Brillantes collaborates with scholars based in France and United States. Bobby Brillantes's co-authors include Jian Wu, Hong Li, Kenneth W. Bair, Lisa D. Belmont, Eric Cheng, Weiru Wang, Lisa Crocker, Peter S. Dragovich, Yen‐Ching Ho and Yang Xiao and has published in prestigious journals such as Nature and PLoS ONE.

In The Last Decade

Bobby Brillantes

1 paper receiving 29 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bobby Brillantes France 1 21 20 14 11 9 2 30
Fengtian He China 3 11 0.5× 3 0.1× 25 1.8× 6 0.5× 29 3.2× 5 43
Yohta Shimada Japan 3 3 0.1× 5 0.3× 15 1.1× 5 0.5× 15 1.7× 3 34
Mark Palermo United States 2 5 0.2× 6 0.3× 6 0.4× 3 0.3× 2 15
Godelieve Meunier France 2 2 0.1× 2 0.1× 16 1.1× 11 1.0× 25 2.8× 3 36
Farzaana Adam Malaysia 2 2 0.1× 14 0.7× 5 0.4× 3 0.3× 3 23
Connie J. Hinz United States 3 15 0.8× 10 0.7× 6 0.7× 5 27
Lakshmi Chilukuri United States 2 8 0.4× 12 0.9× 2 0.2× 2 0.2× 4 26
Guilan Wen China 2 23 1.1× 7 0.5× 16 1.8× 7 25
Sarah Vidito United States 4 2 0.1× 12 0.6× 6 0.4× 4 20
Carolin Sachs United States 3 12 0.6× 6 0.4× 1 0.1× 9 1.0× 4 19

Countries citing papers authored by Bobby Brillantes

Since Specialization
Citations

This map shows the geographic impact of Bobby Brillantes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobby Brillantes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobby Brillantes more than expected).

Fields of papers citing papers by Bobby Brillantes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bobby Brillantes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobby Brillantes. The network helps show where Bobby Brillantes may publish in the future.

Co-authorship network of co-authors of Bobby Brillantes

This figure shows the co-authorship network connecting the top 25 collaborators of Bobby Brillantes. A scholar is included among the top collaborators of Bobby Brillantes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bobby Brillantes. Bobby Brillantes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

2 of 2 papers shown
2.
Wang, Weiru, Kristi Elkins, Angela Oh, et al.. (2014). Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors. PLoS ONE. 9(10). e109366–e109366. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026